Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
Clinical trial NCT01528345 · TERMINATED
Trial details
- NCT number
- NCT01528345
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2015-04-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.